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Abstract
Background: This study aimed to examine the effects of intermittent and continuous swimming training on
muscle protein metabolism in neonatal alloxan-administered rats.
Methods: Wistar rats were used and divided into six groups: sedentary alloxan (SA), sedentary control (SC),
continuous trained alloxan (CA), intermittent trained alloxan (IA), continuous trained control (CC) and intermittent
trained control (IC). Alloxan (250 mg/kg body weight) was injected into newborn rats at 6 days of age. The
continuous training protocol consisted of 12 weeks of swimming training in individual cylinder tanks while
supporting a load that was 5% of body weight; uninterrupted swimming for 1 h/day, five days a week. The
intermittent training protocol consisted of 12 weeks of swimming training in individual cylinder tanks while
supporting a load that was 15% of body weight; 30 s of activity interrupted by 30 s of rest for a total of 20 min/
day, five days a week.
Results: At 28 days, the alloxan animals displayed higher glycemia after glucose overload than the control animals.
No differences in insulinemia among the groups were detected. At 120 days, no differences in serum albumin and
total protein among the groups were observed. Compared to the other groups, DNA concentrations were higher
in the alloxan animals that were subjected to continuous training, whereas the DNA/protein ratio was higher in
the alloxan animals that were subjected to intermittent training.
Conclusion: It was concluded that continuous and intermittent training sessions were effective in altering muscle
growth by hyperplasia and hypertrophy, respectively, in alloxan-administered animals.
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1. Background
Diabetes is a group of metabolic disorders characterized
by hyperglycemia resulting from defects in insulin secre-
tion or insulin action [1-3], which leads to changes in
carbohydrate, fat and protein metabolism. The chronic
hyperglycemia of diabetes is associated with dysfunction
and failure of various organs and tissues, including mus-
cle. Type 1 diabetes mellitus (T1DM) is a multifactorial
autoimmune disease in which susceptibility is deter-
mined by a combination of genetic and environmental
factors [2,4]. The disease is characterized by chronic
hyperglycemia and by the development of specific vascu-
lar alterations [2,5]. In this diabetes type, there is a T
cell-mediated destruction of the insulin secreting b-cells
of the pancreatic islets. Type 2 diabetes (T2DM)
accounts for approximately 90 to 95% of diabetics and
may be promoted by several factors, such as obesity, a
high calorie diet and physical inactivity [2,6]. T2DM is
characterized by a combination of insulin resistance and
a compensatory response to inadequate insulin secre-
tion, which leads to the characteristic hyperglycemia
[2,7]. Currently, it has been observed that T2DM
changes the serum levels of several amino acids that
may contribute to disturbances in insulin secretion and
action [8].
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great importance in improving the level of physical fit-
ness and quality of life. Exercise has been increasingly
recommended in the prevention and rehabilitation of
cardiorespiratory diseases, osteoporosis, diabetes, and in
combating stress [9-11]. Particularly, in the treatment of
T2DM, regular physical exercise at different intensities
improves glucose tolerance and reduces insulin resis-
tance. However, the literature lacks direct evidence on
the preventive effect of exercise on the development of
T2DM; in particular, investigations into the effect of
effort intensity and different exercise protocols is lacking
because this type of research is more difficult to conduct
in humans. In this context, animal models are more sui-
table for the study of these issues.
Beta-cytotoxic chemical agents have been widely and
successfully employed as experimental model for studies
of the diabetes-induced complications successfully
[12-14] Alloxan is a drug widely used as a diabetes
experimental model. This drug, presents an effect selec-
tively toxic on the beta cells from the islets of Langer-
hans in the pancreas [15]. It is known that the
application of diabetogenic drugs in adult animals pro-
duces severe diabetes and in many cases requires the
u s eo fi n s u l i nw h e nr a t sn e e dt os u r v i v ef o ral o n g e r
period of time [16], but in newborn animals a few days
after the drug administration occurs a decrease in pan-
creatic insulin production. From this phase on, b cells
regenerated spontaneously, by replication and/or neo-
genesis [17], reaches 50% of the value presented for con-
trol animals [18].
Portha et al. [18] described an experimental model of
neonatal diabetes in Wistar rats by the application of
streptozotocin on the day of birth. In this model, it was
demonstrated that hyperglycemia is transitory. The
blood glucose levels normalize after the first week of
life, with restoration of insulin production and b-cell
mass. That study features a T2DM model in rats, in
which the experimental animals presented good survival
[18]. Takada et al. [19] using the neonatal streptozotocin
model - administered in the animals on the 5th day of
life, showed that after 12 weeks of the experiment the
pancreatic insulin content decreased and impaired glu-
cose tolerance. Moreover, in another study using the
streptozotocin application as an experimental model in
which it was administrated at 4 days after birth, it was
observed, after three weeks of streptozotocin injection, a
72% decrease in pancreatic insulin stores without
change in pancreatic glucagon stores [20].
Later, Kodama et al. [21] developed another model
that replaced streptozotocin with alloxan. In that study,
alloxan was administered on the 2th, 4th or 6th days of
life. When analyzed at 60 days of life, the rats that
received alloxan on the 2th of life showed blood glucose
levels in the fed state that were slightly higher than
those of the control rats, whereas the rats that received
the drug on the 4th and 6th days showed blood glucose
levels that were significantly higher than those of the
controls. The authors considered a useful model for stu-
dies on chronic complications of diabetes. However,
they emphasized that more studies were needed to
determine whether the alloxan-administered neonatal
rats showed characteristics of T2DM, as was seen in the
streptozotocin neonatal model.
Oliveira et al. [22] examined the fasting plasma glu-
cose and glucose tolerance in the male rats at 30, 60,
and 90 days old after receiving alloxan on the 2nd day
of life. Fasting glucose was not different from control
rats at any time. At 90 days the static insulin secretion
by the pancreatic islets of the animals was similar
among the groups at 2.8 and 5.6 mM of glucose, but
the pancreatic insulin content of the alloxan group was
smaller than the control group [17]. Contarteze et al.
[23] showed that these animals presented higher blood
glucose levels after an oral glucose load than controls.
Similar results were reported by Cimbiz et al. [3], in
which the alloxan group presented higher blood fasting
glucose levels than the control group. Ribeiro et al. [24],
during a glucose tolerance test in rats that received
alloxan on the 6th day of life, also showed higher blood
glucose values in the alloxan group compared to the
control group at 28 days old and 60 days old. Moreover
at 60 days old, it was observed lower insulin secreted by
the isolated islets in relation to the control group for
the glucose concentration of 16.7 mM. Taken together,
these data show that the neonatal alloxan administration
model illustrates interesting features for studying the
role of exercise in preventing and treating diabetes. Stu-
dies using different training protocols in the prevention
and treatment of T2DM are scarce especially in relation
to protein metabolism.
A study in rats that were subjected to the neonatal
application of alloxan and continuous swimming train-
ing at moderate intensity showed that the total serum
protein and skeletal muscle protein content did not
change after 8 weeks of exercise training [22]. Luciano
and Mello [25], using the alloxan model of diabetes in
adult rats, did not observe any differences in total pro-
tein and albumin concentrations between the groups
after 4 weeks of moderate continuous swimming
training.
In adult alloxan-mediated diabetic rats Leme et al.
[26], there were no changes in serum albumin after 8
weeks of continuous swimming exercise at an intensity
of 90% the maximal lactate steady state. On the other
hand, non-diabetic rats that were subjected to high-
intensity intermittent training showed higher expression
of GLUT-4 protein in skeletal muscle [27]. Fedele et al.
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partial pancreatectomy diabetic animals did not show
increased protein synthesis after acute resistance train-
ing. Therefore, it seems that both continuous and inter-
mittent training may play important roles in the
prevention and treatment of diabetes, but further studies
are needed to characterize the intensity and frequency
that are best suited to each of these protocols. In this
context, the present study aimed to examine the effects
of intermittent and continuous training on muscle pro-
tein metabolism in neonatal alloxan-administered rats.
2. Methods
2.1 Animals
The studies were conducted on newborn male Wistar
rats that were kept at 25 ± 1°C under a 12 h/12 h light-
dark cycle and fed standard rodent chow and water ad
libitum. During breastfeeding, food and water were
offered ad libitum to the mothers, and the pups were
distributed in litters of eight per dam. All animal experi-
ments were approved by the committee of ethics in ani-
mal research, Taubate University-CEEA/UNITAU,
under protocol n° 019/08.
2.2 Neonatal alloxan administration
At 6 days old, after a 15-h fast, the male pups with a
body weight of 11.9 ± 1.2 g received intraperitoneal
alloxan monohydrate (Sigma-Aldrich Inc., St Louis, MO,
USA) injections (250 mg/kg body weight) that were dis-
solved in 0.01 M citrate buffer at pH 4.5 [29]. Vehicle-
injected (citrate buffer) rats were used as controls.
Immediately, the pups were distributed so that each
mother nursed eight of them.
2.3 Experimental groups
At 28 days old, the animals were randomly divided into
six groups of 10 rats each and remained under observa-
tion until 120 days old (Figure 1):
- Sedentary Control (SC): citrate buffer-injected rats
that were not subjected to exercise training
- Continuous Training Control (CC): citrate buffer-
injected rats that were subjected to the continuous exer-
cise training protocol.
- Intermittent Training Control (IC): citrate buffer-
injected rats that were subjected to the intermittent
exercise training protocol.
- Sedentary Alloxan (SA): alloxan-injected rats that
were not subjected to exercise training.
- Continuous Training Alloxan (CA): alloxan-injected
rats that were subjected to the continuous exercise
training protocol.
- Intermittent Training Alloxan (IA): alloxan-injected
rats that were subjected to the intermittent exercise
training protocol.
2.4 Exercise training
The rats were initially adapted to the water to reduce
the stress caused by the physical exercise performed in
this environment. The adaptation consisted of the fol-
lowing sequence, which was followed by the initiation of
training: 5, 10, and 15 min in shallow water; 5, 10, and
1 5m i ni nd e e pw a t e r ;5m i nw i t hab a gt i e dt ot h e
thorax; and 5, 10, and 15 min with a bag containing a
load of 3% of body weight tied to the thorax. Between
weaning and 120 days of age, the animals that were
trained with the continuous exercise protocol were sub-
jected to 1 hour per day, five days a week, of uninter-
rupted swimming in individual cylinder tanks (25 cm in
diameter × 50 cm in depth) while supporting a load of
5% of body weight. This intensity corresponds to the
aerobic/anaerobic metabolic transition during swimming
exercise for rats [30]. Between weaning and 120 days of
age, the animals that were trained with the intermittent
protocol were subjected to 5 days a week of swimming
in individual cylinder tanks (25 cm in diameter × 50 cm
in depth) for 30 s interrupted by 30 s of rest for a total
of 20 min per day while supporting a load of 15% of
body weight (adapted from [31]). The water temperature
was maintained at 31 ± 1°C, which was considered a
thermally neutral temperature for rats [32,33]. The
training protocols consisted of equivalent total weekly
training load (WL). According to Araújo et al. [34], WL
represents the total of stimuli of training obtained by
the product of the exercise time (t) and the intensity
(%). Therefore, in this study, the continuous training
protocol, in which WL = 60 min × 5% = 300, was
equivalent to the intermittent training protocol, in
which WL = 20 min × 15% = 300.
2.5 In vivo Evaluations
The body weight, food and water intake of all the ani-
mals were registered once a week from weaning on.
They were also evaluated for fasting and non-fasting
blood glucose and insulin levels.
2.5.1 Blood glucose and insulin
The diabetogenic effect of alloxan was confirmed when
the rats were 28 and 120 days old by the determination
of the fasting (after a 12-h fast) and non-fasting (30 min
after administration of glucose solution, 2.0 g [kg body
weight]-1, into the stomach through a gastric catheter)
serum glucose by the oxidase method (Kit glicose -
Laborlab: CAT n° 02200- Guarulhos- SP) and the serum
insulin based on ELISA (Kit Insulina- Diagnostic Sys-
tems Laboratories INC (DSL), REF: 10-1600, 445 medi-
cal Center BLVD, Webster, TX 77598, USA).
2.6. Biological material collection
At 120 days of age, biological material was obtained
from animals that were sacrificed by decapitation after
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body weight) without fasting and 48 hours after the last
in vivo procedure.
2.6.1. Blood
Blood samples were collected to verify the concentra-
tions of glucose (Kit glicose - Laborlab: CAT n° 02200-
Guarulhos- SP), total protein and albumin by spectro-
metry (total protein Kit - Laborlab: CAT n° 03801 e
albumin Kit - Laborlab: CAT n° 03802- Guarulhos- SP)
and serum insulin by ELISA (Kit Insulina-Diagnostic
systems laboratories INC (DSL), REF: 10-1600, 445
medical Center BLVD, Webster, TX 77598, USA).
2.6.2. Adipose Tissue
The adipose tissue of the posterior subcutaneous,
mesenteric and retroperitoneal regions were removed
and weighed for determination of total fat content. Exci-
sion of the different fat deposits was carried out accord-
ing to the description of Cinti [35]
2.6.3. Gastrocnemius muscle
Samples of the gastrocnemius muscle were excised for
the evaluation of total protein [36] and DNA content
[37], to determine the number (DNA) and size (protein/
DNA ratio) of the cells [38].
2.6.4. Soleus muscle
2.6.4.1 Protein Synthesis Longitudinal strips from the
soleus muscle (70 mg) were preincubated for 30 min in
a RPMI 1640 medium (with glutamine and without red
phenol and sodium bicarbonate) that was supplemented
with fat-free 0.1% bovine serum albumin (BSA) and 100
μU ml-1 insulin and saturated with a 95% O2/5% CO2
gas mixture. The strips were then transferred to fresh
RPMI medium, which contained the same supplements
in addition to 0.05 ACi ml-1 [14C] phenylalanine, and
incubated for two more hours. At the end of this incu-
bation, the muscle strips were homogenized in 5% tri-
chloroacetic acid (TCA) and centrifuged at 2000 rpm
for 15 min at 4°C. TCA-insoluble material was washed
three times with 5% TCA. The resulting precipitate was
dissolved for 30 min in 10% sodium dodecyl sulfate at
room temperature to determine both protein content
and the radioactivity incorporated into the muscle pro-
tein. Muscle protein content was determined by the
folin phenol method [38], and the radioactivity incorpo-
rated into the muscle proteins was determined with a
liquid scintillation counter. Protein synthesis was calcu-
lated by dividing the incorporated radioactivity by the
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Figure 1 Experimental Design.
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medium.
2.6.4.2 Protein Degradation Tyrosine liberation by iso-
lated muscles in the presence of cyclohexamide was
employed as the protein degradation index [39]. This
method is based on the fact that the amino acid tyrosine
is neither synthesized nor degraded by skeletal muscle.
Longitudinal strips from the soleus muscle (70 mg) were
preincubated in Krebs-Ringer buffer (NaCl, 1.2 mmol/L;
KCl, 4.8 mmol/L; NaHCO3, 25 mmol/l; CaCl2, 2.5
mmol/L; KH2PO4, 1.2 mmol/l; MgSO4, 1.2 mmol/L;
pH 7.4) that was supplemented with 5.5 mmol/L glu-
cose, 1.34% BSA, 5 AUml-1 insulin, and 5.0 mmol/L
cyclohexamide and saturated with a 95% O2/5% CO2
gas mixture. Subsequently, the muscle strips were trans-
ferred to fresh medium with the same composition and
incubated for two more hours. At the end of the incuba-
tion, the samples of the incubation medium were used
for tyrosine determination [40].
2.6.5. Pancreatic Islets
To measure insulin secretion, groups of five pancreatic
islets isolated by collagenase digestion [41] were incu-
bated for 30 min at 37°C, in Krebs bicarbonate medium
containing glucose (5,6 mM), supplemented with bovine
serum albumin (3 g/l) and balanced with a mixture of
95% O2 -5% CO2; pH 7,4. The solution was then
replaced by fresh buffer, and the islets were incubated
for a further hour with different glucose concentrations
(2.8, 11.1 mM). The insulin content of the incubation
medium was determined by ELISA (Kit Insulina- Diag-
nostic Systems Laboratories INC (DSL), REF: 10-1600,
445 medical Center BLVD, Webster, TX 77598, USA).
2.7. Statistics
Data analysis was performed using the student t-test or
two-way analysis of variance ANOVA followed by Bon-
ferroni post hoc test when appropriate. In all cases, the
level of significance was determined at 5% (p < 0.05).
3. Results
Changes in animal body weight (Figure 2A) during the
experimental period were analyzed by the weight gain
during the experiment, shown in Figure 2B. The IC
g r o u ph a dr e d u c e dw e i g h tg a i nc o m p a r e dt ot h eS C
group, which demonstrates the efficacy of intermittent
training in weight control in the control animals. The
adipose tissue weight of the retroperitoneal, posterior
subcutaneous and mesenteric regions were presented in
Figure 3A, B and Figure 3C, respectively. It was
observed significant difference only in the retroperito-
n e a lf a tc o n t e n ti nw h i c ht h eC Cg r o u ps h o w e ds i g n i f i -
cantly lower values than the IC group.
In Figures 4A and 4B, the values related to food and
water intake, respectively, are presented. No significant
differences among the groups were observed in these
parameters. Table 1 presents the data of the fasting and
non-fasting (after glucose overload) serum glucose and
insulin levels at 28 days of age. After glucose overload,
the alloxan group presented higher serum glucose values
than the control group.
Table 2 shows the fasting and non-fasting (after glu-
cose overload) serum glucose and insulin levels at 120
days of age. The IA group presented higher serum glu-
cose values than the IC group after glucose overload.
At 120 days of age it was evaluated the static insulin
secretion by the pancreatic islets in response to different
glucose concentrations (2.8 and 11.1 mM) which is pre-
sented in the table 3. It was observed significant differ-
ences among the groups. At concentration of 2.8 mM
the SA group showed lower values when compared to
corresponding control. The same was found in the glu-
cose concentration 11.1 mM. Both exercise training pro-
tocols counteracted the alterations at 2.8 mM glucose
concentration. Total serum protein and albumin levels,
DNA content and the protein/DNA ratio in the gastro-
cnemius muscle are presented in Table 4. When total
serum protein and albumin were analyzed, no differ-
ences among the groups were observed. In relation to
the DNA content of the gastrocnemius muscle, the CA
group showed higher values than the IA group. On the
other hand, the protein/DNA ratio was higher in the IA
g r o u pt h a ni nt h eC Ag r o u p ,w h i c hi n d i c a t e sh i g h e r
muscle hypertrophy after intermittent training.
Protein synthesis and degradation in the soleus muscle
did not differ among the groups (Table 5).
4. Discussion
It is known that insulin has effects on glucose, fat and
protein metabolism. Particularly in protein metabolism,
insulin increases the intensity of amino acid transport
across the cell membrane, which increases the available
amino acids for protein synthesis. In diabetes mellitus,
due to changes in insulin production and/or action, pro-
tein metabolism is altered. In turn, physical exercise
promotes muscle protein anabolism, which results in
morphological and metabolic adaptations in skeletal
muscle.
Currently, it has been observed that high-intensity
exercise can effectively increase muscle strength and
mass and improve physical performance and functional
capacity. Thus, the present study investigated the effects
of intermittent and continuous training on protein
metabolism in neonatal alloxan-administered rats.
In this study, the weight gain of animals was analyzed,
and it was observed that the neonatal alloxan adminis-
tration did not affect weight gain. Similar results were
reported by Ribeiro et al. [24] using the same experi-
mental model used in the present study.
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gains in body weight than the control group that was
subjected to the intermittent training protocol, which
demonstrates a beneficial effect of this protocol on
weight control. Furthermore, it is known that over-
weight or obesity are risk factors for the onset of T2DM
[42]. Studies show that adipose tissue distribution is
changed in type 2 diabetes mellitus [43]. Thus this study
analyzed the adipose tissue in the retroperitoneal, sub-
cutaneous and mesenteric regions. No difference was
found in fat mass in the different regions when com-
pared the groups that received the diabetogenic drug
and controls. However, significant difference was found
between the control animals after physical training,
showing a smaller deposit of retroperitoneal fat in ani-
mals that performed continuous training compared to
intermittent training. This demonstrates the beneficial
effect of exercise to reduce abdominal fat [44] which
high risk of developing metabolic complications such as
impaired glucose tolerance, insulin resistance [45].
With respect to food and water intake of the animals,
no difference was found among the groups, which
shows that neonatal alloxan administration did not lead
to polyphagia or polydipsia, which are usually observed
in adult alloxan-mediated diabetic animals [46].
T2DM leads to glucose intolerance and insulin resis-
tance, therefore, to evaluate changes in glucose homeos-
tasis, the fasting and non-fasting (after glucose overload)
serum glucose and insulin levels were determined at 28
and 120 days of age. At 28 days, glucose intolerance,
which was indicated by the higher values of glycemia 30
min after the oral glucose overload, was observed to a
greater extent in the alloxan group compared to the
control group, which confirms the findings of a previous
study [23]. At 120 days, glycemia after glucose overload
was higher in the intermittent trained alloxan group
compared to the corresponding control group, which
was evidence for the differences in glucose homeostasis
between the alloxan and control groups. After static
insulin secretion by the isolated pancreatic islets in
response to different glucose concentrations evaluation,
it was evident the alloxan effect, because at lower and
high glucose concentrations (2.8 and 11.1 mM) the
sedentary alloxan animals had lower insulin secretion
compared to the sedentary controls. On the other hand
in the Oliveira et al. [22] study, using similar experimen-
tal model, no significant difference was found between
animals that received the drug in 2 days of age and the
control rats in the insulin secretion at different glucose
concentrations (2.8 e 16.7 mM). Furthermore, it was
observed in the present study that physical training has
an important role in improving insulin secretion. At low
glucose concentrations (2.8 mM) both exercise training
protocols avoided the decrease in glucose induced insu-
lin secretion caused by alloxan administration. Similar
results were described in a previous study where the
rats that received alloxan at 2 days of age and performed
continuous training had better insulin secretory
response compared to the sedentary animals [22].
The growth of organs can be caused by an increase in
cell number (hyperplasia), an increase in cell size
(hypertrophy) or by both processes simultaneously. The
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determining the total DNA content of the organ and
dividing by a constant that represents the DNA content
per diploid nucleus in the species being studied [38].
Determined the number of cells, the average weight, the
protein content and the RNA content per cell, among
others, can be assessed by determining the total quantity
of each element and dividing by the number of cells.
The result can be expressed as weight/DNA, protein/
DNA, RNA/DNA ratios, etc. [38].
An increase in DNA content represents one type of
growth: increased cell number; an increase in the
weight/DNA, protein/DNA and RNA/DNA ratios
represent another aspect of growth: increased tissue
mass without an increase in cell number [38]. In the
rats between 0 and 20 days old, all organs grow by cell
division only, whereas between 21 and 42 days, most
organs, including striated skeletal muscle, grow by
both cellular hyperplasia and hypertrophy; between 64
and 86 days, all organs grow by cellular hyperplasia
[38]. Physiological alterations during the hyperplastic
and/or hypertrophic growth of an organ may result in
changes in the number and/or size of the cells in the
organ.
Therefore, in the present study, the protein, DNA
content and protein/DNA ratio in the gastrocnemius
muscle were analyzed. The alloxan group that was sub-
jected to the continuous training showed higher DNA
content and lower protein/DNA ratios than that of the
intermittent training alloxan group, which indicates that
continuous training was effective in promoting muscle
hyperplasia, whereas intermittent training resulted in
greater muscle hypertrophy. In previous studies, it was
showed that exercise training increased serum and mus-
cle IGF-1 concentrations in diabetic rats [47-50]. Thus,
in the present study, the alterations in muscle mass in
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related to a possible increase in IGF-1 levels.
In an attempt to elucidate the possible mechanisms
involved in cellular growth alterations in skeletal muscle
that are induced by exercise training, protein synthesis
and degradation rates were evaluated in the soleus mus-
cle, but no differences were observed among the groups.
Fedele et al. [28] also found no change in muscle pro-
tein synthesis in diabetic rats after acute resistance
training. On the other hand, Farrell et al. [51] showed
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Figure 4 Food intake and water intake of the animals at weaning (28 days) until the end of the experiment (120 days).R e s u l t sa r e
expressed as means ± standard deviation of 10 animals per group. SA: Sedentary alloxan, SC: Sedentary control, CC: Continuous training control,
CA: Continuous training alloxan, IC: Intermittent training control and IA: Intermittent training alloxan.
Table 1 Fasting (12 hs) and non fasting (after glucose
overload) serum glucose and insulin levels at weaning
(28 days).
28 days Alloxan Control
Fasting serum glucose (mg/dL) 82.1 ± 8.6 81.8 ± 6.7
Non fasting serum glucose (mg/dL) 200.6 ± 35.0 * 155.3 ± 11.2
Fasting insulin level (ng/mL) 0.43 ± 0.27 0.61 ± 0.41
Non Fasting insulin level (ng/mL) 0.84 ± 0.39 0.79 ± 0.48
Results are expressed as means ± standard deviation of 10 animals per group.
*, statistically significant different (student test, p < 0.05) from control group.
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Page 8 of 11that diabetic rats presented a higher muscle protein
synthesis after moderate endurance training.
Compared to aerobic training, which involves mainly
oxidative fibers, generates increased mitochondrial activ-
ity and has a reduced effect on protein metabolism, high
intensity training involves a greater participation of gly-
colytic type fibers and a greater increase in mass as well
as increased protein synthesis. Therefore, in the present
study, protein changes may not have been evident after
intermittent training because the muscle fibers that
were analyzed have predominantly oxidative
characteristics.
Table 2 Fasting (12 hs) and non fasting (after glucose overload) serum glucose and insulin levels at 120 days.
120 days SA SC CC CA IC IA
Fasting serum glucose (mg/dL) 79.38
± 6.62
78.93
± 3.54
75.83
± 4.28
77.61
± 4.28
78.00
± 7.05
77.74
± 5.96
Non fasting serum glucose (mg/dL) 132.03 ± 16.38 115.74
± 5.16
118.77
± 8.07
124.42
± 13.17
105.42
± 5.41
125.44 ± 18.80
f
Fasting insulin level
(ng/mL)
0.84
± 0.61
1.90
± 1.04
2.10
± 1.59
0.72
± 0.44
1.28
± 1.00
1.53
± 0.94
Non fasting insulin level
(ng/mL)
3.72
± 2.71
2.74
± 1.98
2.29
± 1.66
1.97
± 1.40
3.96
± 2.55
3.71
± 1.85
Results are expressed as means ± standard deviation of 10 animals per group. SA: Sedentary alloxan, SC: Sedentary control, CC: Continuous training control, CA:
Continuous training alloxan, IC: Intermittent training control and IA: Intermittent training alloxan. Letter indicate a statistically significant difference among groups
(Two- way ANOVA (3 × 2) and Bonferroni post hoc test, p < 0.05) referring to non-fasting serum glucose. f, statistically significant difference for IA vs. IC.
Table 3 Static insulin secretion (ng/5 islets × h) by the isolated pancreatic islets in response to different glucose
concentrations (2
Glucose Concentration SA SC CC CA IC IA
2.8 mM 0.92 ± 0.17
a 1.56 ± 0.40 1.52 ± 0.36 1.32 ± 0.44 0.63 ± 0.28
h, i 1.97 ± 0.48
c, d, f
11.1 mM 10.65 ± 3.76
a 25.00 ± 6.08 26.36 ± 7.76 17.43 ± 3.13
e 4.69 ± 2.28
h, i 5.94 ± 2.60
d
Results are expressed as means ± standard deviation of 10 animals per group. SA: Sedentary alloxan. SC: Sedentary control. CC: Continuous training control. CA:
Continuous training alloxan. IC: Intermittent training control and IA: Intermittent training alloxan. Letter indicate a statistically significant difference among groups
(Two- way ANOVA (3 × 2) and Bonferroni post hoc test. p < 0.05) referring to non fasting serum glucose. a. statistically significant difference for SA vs SC; c.
statistically significant difference for SA vs IA; d. statistically significant difference for CA vs IA; e. statistically significant difference for CA vs CC; f. statistically
significant difference for IA vs. IC; h. statistically significant difference for SC vs IC; i. statistically significant difference for CC vs IC.
Table 5 Protein synthesis and degradation in the soleus
muscle of the animals at 120 days.
SA SC CC CA IC IA
Protein synthesis
(pmol/mg.h)
11.06
± 2.21
12.77
± 5.76
19.40
± 3.82
13.68
± 6.37
14.46
± 2.59
11.14
± 2.21
Protein
degradation
(pmol/mg.h)
350.56
± 90.71
287.93
± 37.38
271.29
± 89.94
244.04
± 44.26
387.00
± 95.74
322.49
± 93.99
Results are expressed as means ± standard deviation of 10 animals per group.
SA: Sedentary alloxan, SC: Sedentary control, CC: Continuous training control,
CA: Continuous training alloxan, IC: Intermittent training control and IA:
Intermittent training alloxan.
Table 4 Total serum protein and albumin levels, protein level, DNA content and the protein/DNA ratio in the
gastrocnemius muscle of the animals at 120 days.
SA SC CC CA IC IA
Total serum protein
(g/L)
7.08
± 0.08
7.05
± 0.22
7.12
± 0.16
7.20
± 0.13
7.17
± 0.18
7.19
± 0.11
Serum albumin
(g/L)
4.78
± 0.37
4.82
± 0.28
4.98
± 0.36
4.87
± 0.45
5.04
± 0.36
5.33
± 0.86
Protein gastrocnemius
(mg/100 mg)
6.01
± 1.37
6.09
± 0.86
6.51
± 1.25
5.39
± 1.32
5.55
± 1.22
6.38
± 0.81
DNA gastrocnemius
(mg/100 mg)
0.053 ± 0.013 0.058
± 0.010
0.069 ± 0.016 0.071 ± 0.021 0.051
± 0.012
0.050
± 0.016
d
Protein/DNA gastrocnemius 110.35
± 20.37
108.02
± 27.80
95.35
± 15.17
84.95
± 37.15
115.61
± 39.29
146.27
± 69.28
d
Results are expressed as means ± standard deviation of 10 animals per group. SA: Sedentary alloxan, SC: Sedentary control, CC: Continuous training control, CA:
Continuous training alloxan, IC: Intermittent training control and IA: Intermittent training alloxan. Letter indicate a statistically significant difference among groups
(Two- way ANOVA (3 × 2) and Bonferroni post hoc test, p < 0.05) referring DNA and Protein/DNA ratio. d, statistically significant difference for CA vs. IA.
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Page 9 of 11In conclusion, neonatal alloxan administration reduced
glucose-induced insulin secretion by pancreatic islet.
Although the alloxan administered rats did not show
overt diabetes mellitus, the glucose homeostasis was
impaired, as indicated by their glucose intolerance. The
continuous and intermittent training protocols were
effective in preventing the reduction in glucose-induced
insulin secretion by pancreatic islets of the alloxan
administered animals. The continuous training also
improved glucose tolerance. Both exercise raining proto-
cols were effective in altering muscle growth by hyper-
plasia and hypertrophy, respectively, in the alloxan
animals. Additional studies are needed to elucidate the
possible mechanisms that are involved in these
alterations.
List of abbreviations
T1DM: Type 1 diabetes mellitus; T2DM: Type 2 diabetes mellitus; WL: total
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